Moody National Bank Trust Division’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,341
Closed -$303K 481
2024
Q1
$303K Hold
10,341
0.02% 392
2023
Q4
$376K Buy
10,341
+1,331
+15% +$43.6K 0.03% 383
2023
Q3
$289K Buy
9,010
+1,418
+19% +$48.2K 0.02% 505
2023
Q2
$238K Buy
+7,592
New +$173K 0.02% 563
2019
Q2
Sell
-120
Closed -$5K 888
2019
Q1
$5K Buy
+120
New +$6.12K ﹤0.01% 957

Other funds holding SRDX

Moody National Bank Trust Division's SRDX Position: Q2 2024 in Review

Moody National Bank Trust Division sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 10,341 shares — an estimated $303K sold.

Moody National Bank Trust Division first reported a position in SRDX in Q1 2019 and held it in 5 quarters. The position peaked at $376K in Q4 2023. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Moody National Bank Trust Division reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Moody National Bank Trust Division sold 10,341 Surmodics shares in Q2 2024, an estimated $303K.
  • Moody National Bank Trust Division first reported a position in Surmodics in Q1 2019 and held it in 5 quarters.
  • Moody National Bank Trust Division's Surmodics position peaked at $376K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Moody National Bank Trust Division's 13F filing for Q2 2024, filed 3 Jul 2024.